Departamento de Ciencias Médicas, Universidad de Guanajuato, Campus León, León, Mexico.
Hospital Regional de Alta Especialidad del Bajío, León, Guanajuato, Mexico.
J Gastrointest Surg. 2023 Sep;27(9):1778-1784. doi: 10.1007/s11605-023-05699-5. Epub 2023 May 25.
A therapeutic approach to severe obesity is bariatric surgery (BS), which is considered an effective intervention for ameliorating comorbidities such as T2DM, hypertension, dyslipidemia, and cardiovascular diseases. Some polymorphisms are considered markers for addictive disorders and hedonic hunger. We analyzed factors associated with the outcomes of BS, including rs1800497 ANKK1 and rs1799732 DRD2 polymorphisms, eating behavior, hedonic hunger, and depressive symptoms.
We retrospectively selected 101 patients who underwent BS and agreed to participate. The previous conditions to BS, such as body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), and comorbidities, were registered; the scholarship value was evaluated as the total number of years of scholarly education. To evaluate the post-surgery conditions of the participants, we took blood samples, anthropometric measures, and 3 questionnaires to evaluate eating behavior (TFEQ-R18), hedonic hunger (PFS), and depressive symptoms (PHQ-9). The ANKK1 rs1800497 and rs1799732 DRD2 polymorphisms were genotyped.
The median total weight loss (TWL) was 34.7 kg, with a BMI of 33.8 kg/m, 6 (4-8) years after BS. The TWL was positively associated with the TFEQ-R18 score (p = 0.006) and negatively associated with triglycerides (p = 0.011). rs1800497 ANKK1 was associated with TFEQ-R18 (OR = 1.13 (1.02-1.25), p = 0.009). We also found a negative correlation of pre-surgery BMI with scholarship (r = - 0.27, p < 0.05).
The patients showed an improvement in metabolic and anthropometric parameters post-surgery. Interestingly, the ANKK1 Taq1A polymorphism was associated with eating behavior and scholarship with pre-surgery BMI, which may be considered predictors of BS outcomes.
治疗严重肥胖的方法是减肥手术(BS),它被认为是改善 2 型糖尿病、高血压、血脂异常和心血管疾病等合并症的有效干预措施。一些多态性被认为是成瘾障碍和享乐性饥饿的标志物。我们分析了与 BS 结果相关的因素,包括 rs1800497 ANKK1 和 rs1799732 DRD2 多态性、饮食行为、享乐性饥饿和抑郁症状。
我们回顾性选择了 101 名接受 BS 并同意参与的患者。BS 前的情况,如体重指数(BMI)、收缩压(SBP)、舒张压(DBP)和合并症,都有登记;奖学金价值评估为受教育年限总和。为了评估参与者手术后的情况,我们采集了血液样本、人体测量学指标和 3 份问卷来评估饮食行为(TFEQ-R18)、享乐性饥饿(PFS)和抑郁症状(PHQ-9)。ANKK1 rs1800497 和 rs1799732 DRD2 多态性进行了基因分型。
中位总体重减轻(TWL)为 34.7kg,BMI 为 33.8kg/m,BS 后 6(4-8)年。TWL 与 TFEQ-R18 评分呈正相关(p=0.006),与甘油三酯呈负相关(p=0.011)。rs1800497 ANKK1 与 TFEQ-R18 相关(OR=1.13(1.02-1.25),p=0.009)。我们还发现术前 BMI 与奖学金呈负相关(r=-0.27,p<0.05)。
患者术后代谢和人体测量参数得到改善。有趣的是,ANKK1 Taq1A 多态性与饮食行为和奖学金相关,而术前 BMI 与奖学金相关,这可能被认为是 BS 结果的预测因素。